|
Market Closed -
Euronext Paris
12:55:00 2026-10-30 EDT
|
5-day change | 1st Jan Change | ||
| 2.453 EUR | -4.10% |
|
+5.46% | -34.02% |
| 10-08 | Valneva Says UK Revokes Chikungunya Virus Vaccine's Marketing Authorization; Shares Down Pre-Bell | MT |
| 10-08 | Valneva: United Kingdom Withdraws IXCHIQ Authorization |  |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 519M | - | ||||
| 63.77B | |||||
| 56.37B | |||||
| 54.62B | |||||
| 44.06B | |||||
| 42.11B |
- Stock Market
- Stocks
- VLA Stock
- Charts Valneva SE
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
